Antineoplastic Action of Growth Hormone-Releasing Hormone (GHRH) Antagonists

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 7, Iss. 1, 2012-01 ,pp. : 56-63

Bentham Science Publishers

Access to resources Recommend Favorite

Growth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancers. Letsch M, Schally AV, Busto R, Bajo AM, Varga JL, Endocrine, Polypeptide and Cancer Institute, Veterans Affairs Medical Center, and Section of Experimental Medicine, Department of Medicine, Tulane University School of Medicine, New Orleans, LA - Proc Natl Acad Sci USA 2003;100:1250-1255

By Trump D.L.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 5, 2003-09 ,pp. : 411-412

Elsevier

Access to resources Recommend Favorite

Suppression of the proliferation of human U-87 MG glioblastoma cells by new antagonists of growth hormone-releasing hormone in vivo and in vitro

By Jaszberenyi Miklos   Schally Andrew   Block Norman   Zarandi Marta   Cai Ren-Zhi   Vidaurre Irving   Szalontay Luca   Jayakumar Arumugam   Rick Ferenc  

Targeted Oncology, Vol. 8, Iss. 4, 2013-12 ,pp. : 281-290

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of Growth of Androgen-independent DU-145 Prostate Cancer In Vivo by Luteinising Hormone-releasing Hormone Antagonist Cetrorelix and Bombesin Antagonists RC-3940-II and RC-3950-II

By Jungwirth A.   Pinski J.   Galvan G.   Halmos G.   Szepeshazi K.   Cai R.Z.   Groot K.   Vadillo-Buenfil M.   Schally A.V.  

European Journal of Cancer, Vol. 33, Iss. 7, 1997-06 ,pp. : 1141-1148

Elsevier

Access to resources Recommend Favorite

Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: Relevant clinical aspects

By Doga M.   Bonadonna S.   Burattin A.   Giustina A.  

Annals of Oncology, Vol. 12, Iss. 2, 2001-02 ,pp. : 89-94

Springer Publishing Company

Access to resources Recommend Favorite